HFA
CRVO icon

Hoover Financial Advisors’s CervoMed CRVO Stock Holding History

Hoover Financial Advisors’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$3K Buy
+56
New +$3.09K ﹤0.01% 573

Other funds holding CRVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return

Hoover Financial Advisors's CRVO Position: Q2 2021 in Review

Hoover Financial Advisors opened a new position in CervoMed (CRVO) in Q2 2021: 56 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #573 among its holdings.

24 funds tracked by Wall St. Rank hold CRVO as of Q2 2021.

  • Hoover Financial Advisors held 56 shares of CervoMed worth $3K as of Q2 2021.
  • CervoMed was a new Hoover Financial Advisors position in Q2 2021.
  • CervoMed made up ﹤0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #573 holding.
  • 24 funds tracked by Wall St. Rank held CervoMed as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.